Schizophrenia postmortem brain is characterized by gamma aminobutyric acid downregulation and by decreased dendritic spine density in frontal cortex. Protracted L-methionine treatment exacerbates schizophrenia symptoms, and our earlier work (Tremolizzo et al. and Dong et al.) has shown that L-methionine decreases reelin and GAD67 transcription in mice which is prevented by co-administration of valproate. In this study, we observed a decrease in spine density following L-methionine treatment, which was prevented by co-administration of valproate. Together with our earlier findings conducted under the same experimental conditions, we suggest that downregulation of spine density in L-methionine-treated mice may be because of the decreased expression of reelin and that valproate may prevent spine downregulation by inhibiting the methylation induced decrease in reelin.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2882068PMC
http://dx.doi.org/10.1097/WNR.0b013e3283373126DOI Listing

Publication Analysis

Top Keywords

spine density
16
l-methionine decreases
8
dendritic spine
8
frontal cortex
8
l-methionine treatment
8
prevented co-administration
8
co-administration valproate
8
spine
5
l-methionine
4
decreases dendritic
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!